Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Acme Packet Announces Stock Repurchase, Sending Stock Higher

From Bedford, Mass., late Thursday came the announcement from Acme Packet (APKT) that its board of directors was authorizing a $200 million common-stock repurchase over the next 12 months. As of the end of March, the company said it held more than $400 million in cash and had more than 68 million shares outstanding.

The Safest Way to Invest in "the Cloud" and Earn 5% Yields

In the press release, Acme Packet hedged its bets, giving no obligations that the company would follow through on the entire authorized amount and saying its board may suspend the program at any time, depending on market conditions. Those conditions were favorable for the company in the short-term: after this announcement, Acme Packet shares spiked and were up nearly 6 percent premarket Friday at about $16.50 per share.

In announcing the program through a press release, CEO Andy Ory said, “This common stock repurchase program demonstrates the confidence that the Board of Directors has in the prospects of the Company and further expresses its commitment to enhancing shareholder value.”

This would seem to be very welcome news for a few hedge funds, most noteworthy being Ken Griffin’s Citadel Investment Group and Stuart Peterson’s Artis Capital Management. Artis was invested for $21 million in Acme Packet at the end of March, but had shed 40 percent of its shares during Q1 of 2012. However, Citadel had boosted its share by more than 400 percent in the first quarter, holding $16.2 million in value at the end of March. Christopher Lord of Criterion Capital put out a million-share call option on the stock at the end of March – totaling more than $27 million.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!